Insulet Corp.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45784P1012
USD
219.84
-16.23 (-6.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
ResMed, Inc.
STERIS Plc (Ireland)
Waters Corp.
Insulet Corp.
Hologic, Inc.
Align Technology, Inc.
Revvity, Inc.
EXACT Sciences Corp.
Zimmer Biomet Holdings, Inc.
The Cooper Cos., Inc.
Baxter International, Inc.

Why is Insulet Corp. ?

1
Poor Management Efficiency with a low ROCE of 11.86%
  • The company has been able to generate a Return on Capital Employed (avg) of 11.86% signifying low profitability per unit of total capital (equity and debt)
2
Healthy long term growth as Net Sales has grown by an annual rate of 24.53% and Operating profit at 55.87%
3
Flat results in Dec 25
  • NET PROFIT(9M) At USD 276.71 MM has Grown at -24.56%
  • ROCE(HY) Lowest at 18.12%
  • INTEREST(Q) At USD 19.6 MM has Grown at 25.64%
4
With ROCE of 23.16%, it has a very expensive valuation with a 13.25 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -10.15%, its profits have fallen by -14.9%
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Below par performance in long term as well as near term
  • Along with generating -10.15% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Insulet Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Insulet Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Insulet Corp.
-10.15%
0.36
39.69%
S&P 500
20.12%
1.04
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
24.53%
EBIT Growth (5y)
55.87%
EBIT to Interest (avg)
3.49
Debt to EBITDA (avg)
3.34
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
0.84
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.86%
ROE (avg)
16.61%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
68
Industry P/E
Price to Book Value
15.73
EV to EBIT
57.21
EV to EBITDA
45.76
EV to Capital Employed
13.25
EV to Sales
9.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.16%
ROE (Latest)
22.99%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 569.3 MM

DEBT-EQUITY RATIO (HY)

Lowest at 18.86 %

RAW MATERIAL COST(Y)

Fallen by -0.06% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.71 times

NET SALES(Q)

Highest at USD 783.8 MM

OPERATING PROFIT(Q)

Highest at USD 176.9 MM

PRE-TAX PROFIT(Q)

Highest at USD 140.1 MM

NET PROFIT(Q)

Highest at USD 101.53 MM

EPS(Q)

Highest at USD 1.44

-12What is not working for the Company
NET PROFIT(9M)

At USD 276.71 MM has Grown at -24.56%

ROCE(HY)

Lowest at 18.12%

INTEREST(Q)

At USD 19.6 MM has Grown at 25.64%

Here's what is working for Insulet Corp.

Operating Cash Flow
Highest at USD 569.3 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at 18.86 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Sales
Highest at USD 783.8 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 783.8 MM has Grown at 31.18%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 176.9 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD 140.1 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 101.53 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 1.44
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Inventory Turnover Ratio
Highest at 1.71 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -0.06% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 30.6 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Insulet Corp.

Interest
At USD 19.6 MM has Grown at 25.64%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)